Search Prime Contracts

HDTRA124C0014

Definitive Contract
Your Competitors Have a Secret

Thousands of incumbents lose small business status each year - find the contracts they can't win anymore in HigherGov

Free Trial Schedule Demo

Overview

Government Description
ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER
Place of Performance
Carlsbad, CA 92008 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
52
Related Opportunity
Primmune Therapeutics was awarded Definitive Contract HDTRA124C0014 (HDTRA1-24-C-0014) for Oral Broad Spectrum Antiviral Tlr7 Agonist For Treatment Of Lassa Fever worth up to $22,480,552 by Defense Threat Reduction Agency in January 2024. The contract has a duration of 2 years 5 months and was awarded through solicitation RANGE SERVICES full & open with NAICS 541715 and PSC AC33 via basic research acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $19,856,243 and funded backlog of $8,003,586.

DOD Announcements

Jan 2024: Primmune Therapeutics Inc*, San Diego, California, will be awarded a $22,480,552 contract HDTRA1-24-C-0014 for "Oral broad spectrum antiviral TLR7 agonist for treatment of Lassa Fever". This effort will support the Defense Threat Reduction Agency (DTRA) goal of providing counter weapons of mass destruction capabilities to meet current threats and challenges specifically through the development of a timely and effective biological defense solution for Lassa virus infection. The principal place of performance is San Diego, California. Work is expected to be completed by June 30, 2026. Fiscal 24 research and development funds in the amount of $845,610.00 are being obligated at the time of award. This award is the result of a competitive acquisition against the Broad Agency Announcement (BAA) HDTRA1-17-S-0002. SAM.gov was used to solicit proposals and 10 proposals were received. DTRA, DoDAAC HDTRA1, Fort Belvoir, Virginia, is the contracting activity.

Status
(Open)

Last Modified 4/18/24
Period of Performance
1/30/24
Start Date
2/28/25
Current End Date
6/30/26
Potential End Date
19.0% Complete

Obligations and Backlog
$2.6M
Total Obligated
$10.6M
Current Award
$22.5M
Potential Award
12% Funded
$8.0M
Funded Backlog
$19.9M
Total Backlog

Award Hierarchy

Definitive Contract

HDTRA124C0014

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to HDTRA124C0014

Opportunity Lifecycle

Procurement history for HDTRA124C0014

Transaction History

Modifications to HDTRA124C0014

People

Suggested agency contacts for HDTRA124C0014

Competition

Number of Bidders
1
Solicitation Procedures
Basic Research
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
None
IT Commercial Item Category
Not Applicable
Awardee UEI
RCE3KW671H83
Awardee CAGE
8J8L4
Agency Detail
Awarding Office
HDTRA1 DEFENSE THREAT REDUCTION AGENCY
Funding Office
HDTRA1
Created By
natalie.moneyhun2.civ@mail.mil.hdtra1@dtra.mil
Last Modified By
james.rumingan.hdtra1@sa9761.dtra.mil
Approved By
natalie.moneyhun2.civ@mail.mil.hdtra1@dtra.mil

Legislative

Legislative Mandates
None Applicable
Performance District
CA-49
Senators
Dianne Feinstein
Alejandro Padilla
Representative
Mike Levin
Modified: 4/18/24